Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort

[1]  G. Tiscia,et al.  Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort , 2015, BMJ Open.

[2]  U. Kesmodel,et al.  Increased venous thrombosis incidence in pregnancies after in vitro fertilization. , 2014, Human reproduction.

[3]  O. Hovatta,et al.  Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study , 2013, BMJ.

[4]  U. Kesmodel,et al.  No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study. , 2012, Human reproduction.

[5]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[6]  D. Veenstra,et al.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[7]  G D Adamson,et al.  International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. , 2009, Fertility and sterility.

[8]  P. Sandset,et al.  Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. , 2008, American journal of obstetrics and gynecology.

[9]  S. Nelson,et al.  Artificial reproductive technology and the risk of venous thromboembolic disease , 2006, Journal of thrombosis and haemostasis : JTH.

[10]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[11]  M. Margaglione,et al.  Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. , 2004, Human reproduction.

[12]  B. Casetta,et al.  Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. , 1999, Clinical chemistry.

[13]  P. Lindqvist,et al.  Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. , 2012, Fertility and sterility.

[14]  A. Delvigne.  Epidemiology of OHSS , 2009 .

[15]  M. Margaglione,et al.  Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations. , 2002, Haematologica.